Optical Coherence Tomography of Peri-Ocular Skin Cancers: An Optical Biopsy.

Adnexal tumours Basal cell carcinoma Dermatology Eyelids Histopathology Non-melanoma skin cancer Ocular pathology Oculoplastics Optical coherence tomography

Journal

Ocular oncology and pathology
ISSN: 2296-4681
Titre abrégé: Ocul Oncol Pathol
Pays: Switzerland
ID NLM: 101656139

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 01 04 2020
accepted: 24 08 2020
entrez: 13 5 2021
pubmed: 14 5 2021
medline: 14 5 2021
Statut: ppublish

Résumé

Optical coherence tomography (OCT) imaging has been used as a diagnostic tool for retinal disease for several years, and OCT apparatuses are becoming increasingly powerful. However, OCT has yet to reach its full potential in ophthalmology clinics. Alike retinal layers, it has been shown that OCT is able to generate cross-sectional images of the skin and allows visualization of skin lesions in a histopathology-like manner. We aim to validate OCT as an imaging modality for peri-ocular skin cancer. Through a series of cases, we highlight findings for 3 common eyelid malignancies: basal cell carcinoma, squamous cell carcinoma and sebaceous carcinoma. We propose an OCT image-based signature for basal cell carcinoma. This is a prospective study. Fifty-eight lesions suspicious of malignancy from 57 patients were subjected to OCT imaging prior to the surgical excision of the lesion. OCT images were analysed and scored according to previously identified OCT features. Eight representative examples are presented, highlighting the OCT patterns for each malignancy side by side to its corresponding histopathological sections. Out of the 58 lesions analysed, 53 were malignant. A loss of the dermal-epidermal junction is observed in all malignant lesions. A strong link is observed between the presence of subepithelial hyporeflective nests on OCT and the diagnosis of basal cell carcinoma (present in 83% of cases). Conversely, lesions of epithelial origin such as squamous cell carcinoma are most often represented on OCT by acanthosis. Two supplementary cases, one basal cell carcinoma and one sebaceous carcinoma, are provided to illustrate how OCT imaging is a valuable tool in cases where clinical observations may be unusual. We provide evidence supporting the use of OCT for the evaluation of peri-ocular cancers. OCT enables visualization of the skin layers in vivo, before biopsy. Our results show that certain OCT features can contribute to include or exclude a diagnosis of basal cell carcinoma. By integrating this non-invasive imaging methodology into the routine assessment of peri-ocular skin lesions, especially in health care centres where access to specialists is limited, OCT imaging can increase clinical precision, reduce delays in patient referral and enhance patient care.

Identifiants

pubmed: 33981698
doi: 10.1159/000511188
pii: oop-0007-0149
pmc: PMC8077514
doi:

Types de publication

Journal Article

Langues

eng

Pagination

149-158

Informations de copyright

Copyright © 2020 by S. Karger AG, Basel.

Déclaration de conflit d'intérêts

The authors have no conflict of interest to declare.

Références

Ocul Surf. 2015 Jul;13(3):226-35
pubmed: 26045235
Front Neuroanat. 2014 Dec 22;8:151
pubmed: 25565976
Br J Dermatol. 2016 Dec;175(6):1290-1300
pubmed: 27146027
Adv Exp Med Biol. 2020;1213:149-163
pubmed: 32030669
Dermatol Surg. 2013 Apr;39(4):627-33
pubmed: 23293854
Can J Ophthalmol. 2019 Apr;54(2):280-287
pubmed: 30975355
Can J Ophthalmol. 1998 Dec;33(7):377-83
pubmed: 9885753
Cochrane Database Syst Rev. 2018 Dec 04;12:CD013189
pubmed: 30521690
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Eye Vis (Lond). 2019 Aug 27;6:27
pubmed: 31463333
J Eur Acad Dermatol Venereol. 2015 Aug;29(8):1562-9
pubmed: 25640145
Skin Res Technol. 2016 Nov;22(4):395-405
pubmed: 26804618
Br J Dermatol. 2015 Aug;173(2):428-35
pubmed: 25904111
BMJ. 2012 Aug 21;345:e5342
pubmed: 22915688
Br J Dermatol. 2018 May;178(5):1102-1110
pubmed: 29193003
Br J Ophthalmol. 2013 Jul;97(7):890-4
pubmed: 23677987
Ophthalmology. 2015 Nov;122(11):2316-26
pubmed: 26298717
J Am Acad Dermatol. 1997 Dec;37(6):958-63
pubmed: 9418764
J Clin Aesthet Dermatol. 2015 Oct;8(10):14-20
pubmed: 26557214
Ocul Oncol Pathol. 2016 Apr;2(3):123-7
pubmed: 27390743
Arch Dermatol Res. 2011 Sep;303(7):457-73
pubmed: 21647692
Ophthalmic Plast Reconstr Surg. 2012 Jul-Aug;28(4):282-5
pubmed: 22785586
J Drugs Dermatol. 2016 May 1;15(5):545-50
pubmed: 27168263
Eye Vis (Lond). 2019 Jun 18;6:17
pubmed: 31236423
Arch Dermatol Res. 2015 Jan;307(1):1-10
pubmed: 25223745
Br J Ophthalmol. 2014 Jul;98 Suppl 2:ii40-6
pubmed: 24599420
Can J Ophthalmol. 2019 Aug;54(4):431-437
pubmed: 31358140
J Biophotonics. 2011 Aug;4(7-8):544-51
pubmed: 21595042
Eye Vis (Lond). 2018 Jun 12;5:13
pubmed: 29942817

Auteurs

Sabrina Bergeron (S)

The MUHC, McGill University Ocular Pathology and Translational Research Laboratory, McGill University, Montreal, Québec, Canada.

Bryan Arthurs (B)

Department of Ophthalmology, McGill University, Montreal, Québec, Canada.

Debra-Meghan Sanft (DM)

Department of Ophthalmology, McGill University, Montreal, Québec, Canada.

Christina Mastromonaco (C)

The MUHC, McGill University Ocular Pathology and Translational Research Laboratory, McGill University, Montreal, Québec, Canada.

Miguel N Burnier (MN)

The MUHC, McGill University Ocular Pathology and Translational Research Laboratory, McGill University, Montreal, Québec, Canada.
Department of Ophthalmology, McGill University, Montreal, Québec, Canada.

Classifications MeSH